<DOC>
	<DOCNO>NCT01541904</DOCNO>
	<brief_summary>The purpose study evaluate efficacy safety four dose PRO-118 ophthalmic solution ophthalmic solution compare placebo , treatment seasonal ( SAC ) perennial ( PAC ) allergic conjunctivitis .</brief_summary>
	<brief_title>Efficacy Safety PRO-118 Ophthalmic Solution Allergic Conjunctivitis</brief_title>
	<detailed_description>A phase II , double-masked , randomize , placebo-controlled , parallel-group multicenter clinical trial , evaluate compare clinical efficacy safety four dose PRO-118 ophthalmic solution ( PRO-118 0.015 % qd , PRO-118 0.015 % twice daily , PRO-118 0.020 % qd , PRO-118 0.020 % twice daily ) treatment seasonal ( SAC ) perennial ( PAC ) allergic conjunctivitis .</detailed_description>
	<mesh_term>Conjunctivitis</mesh_term>
	<mesh_term>Conjunctivitis , Allergic</mesh_term>
	<mesh_term>Pharmaceutical Solutions</mesh_term>
	<mesh_term>Ophthalmic Solutions</mesh_term>
	<criteria>Patients diagnosis seasonal perennial allergic conjunctivitis . Age ≥ 6 year old screening visit . Male female patient . Applicable patient ≥ 18 year old . Patient sign Informed Consent Form ( ICF ) prior screen procedure . Applicable patient age ≤ 18 year old . Patients Patients'parents legal guardian sign Informed Consent Form ( ICF ) . The patient also provide write assent . Presence form allergic conjunctivitis seasonal perennial allergic conjunctivitis ( Atopic keratoconjunctivitis , giant papillary conjunctivitis ) . Any ophthalmic medication within seven day prior randomization . Patient one blind eye . Visual acuity 20/40 eye . Patients history active stage concomitant ocular disease . Contraindications sensitivity component study treatment . Contact lens user . Ocular surgery within past 3 month . Women use effective mean contraception pregnant nursing . Participation study investigational drug within 90 day previous inclusion . Discontinuation criterion : Patients could discontinue completion study use prohibit medication , adverse event , pregnancy , protocol violation , lack efficacy , administrative reason .</criteria>
	<gender>All</gender>
	<minimum_age>6 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2013</verification_date>
	<keyword>Ocular Allergy .</keyword>
	<keyword>Seasonal Allergic Conjunctivitis</keyword>
	<keyword>Perennial Allergic Conjunctivitis</keyword>
	<keyword>Conjunctivitis , Allergic</keyword>
	<keyword>Ocular Antihistamines .</keyword>
</DOC>